ABSTRACT

Overactive bladder (OAB) affects millions of men and women daily. Given the symptoms of sleep loss, depression, and a lower quality of life than even those with diabetes mellitus, effective and beneficial treatment is a must for these people. Drs Kreder and Dmochowski, both recognized experts on voiding dysfunction and urodynamics, have a

chapter 1|8 pages

Nomenclature

chapter 3|10 pages

Diagnosis of overactive bladder

chapter 5|12 pages

Nocturia

chapter 6|12 pages

Urodynamics

chapter 9|18 pages

Overactive bladder: basic pharmacology

chapter 10|10 pages

Drug delivery and intravesical instillation

chapter 11|14 pages

Pioneering agents: immediate release

chapter 12|6 pages

Tricyclic antidepressants

chapter 14|8 pages

Extended release oral oxybutynin

chapter 16|14 pages

Trospium chloride

chapter 17|16 pages

Darifenacin

chapter 18|10 pages

Solifenacin succinate

chapter 19|10 pages

Transdermal oxybutynin (OxytrolTM)

chapter 22|16 pages

Botulinum toxin (Botox®)

chapter 24|10 pages

Fesoterodine

chapter 25|10 pages

Neuromodulation: mechanisms of action

chapter 27|10 pages

The bion® microstimulator

chapter 29|6 pages

Transvaginal denervation

chapter 30|14 pages

Autoaugmentation

chapter 32|12 pages

Overactive bladder in children

chapter 33|10 pages

Geriatric population

chapter 34|14 pages

Late breaking information